Literature DB >> 18234787

Expansion and exhaustion of T-cell responses during mutational escape from long-term viral control in two DNA/modified vaccinia virus Ankara-vaccinated and simian-human immunodeficiency virus SHIV-89.6P-challenged macaques.

Shanmugalakshmi Sadagopal1, Rama Rao Amara, Sunil Kannanganat, Sunita Sharma, Lakshmi Chennareddi, Harriet L Robinson.   

Abstract

In this study, we monitored the temporal breadths, frequencies, and functions of antiviral CD4 and CD8 T cells in 2 of 22 DNA/modified vaccinia virus Ankara-vaccinated macaques that lost control of a simian-human immunodeficiency virus 89.6P challenge by 196 weeks postchallenge. Our results show that both mutation and exhaustion contributed to escape. With the reappearance of viremia, responding CD8 and CD4 T cells underwent an initial increase and then loss of breadth and frequency. Antiviral gamma interferon (IFN-gamma)- and interleukin 2-coproducing cells were lost before IFN-gamma-producing cells and CD4 cells before CD8 cells. At euthanasia, all CD8, but no CD4, Gag epitopes detected during long-term control contained mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18234787      PMCID: PMC2292989          DOI: 10.1128/JVI.02242-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.

Authors:  D H Barouch; S Santra; J E Schmitz; M J Kuroda; T M Fu; W Wagner; M Bilska; A Craiu; X X Zheng; G R Krivulka; K Beaudry; M A Lifton; C E Nickerson; W L Trigona; K Punt; D C Freed; L Guan; S Dubey; D Casimiro; A Simon; M E Davies; M Chastain; T B Strom; R S Gelman; D C Montefiori; M G Lewis; E A Emini; J W Shiver; N L Letvin
Journal:  Science       Date:  2000-10-20       Impact factor: 47.728

2.  An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants.

Authors:  N F Rose; P A Marx; A Luckay; D F Nixon; W J Moretto; S M Donahoe; D Montefiori; A Roberts; L Buonocore; J K Rose
Journal:  Cell       Date:  2001-09-07       Impact factor: 41.582

3.  Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

Authors:  R R Amara; F Villinger; J D Altman; S L Lydy; S P O'Neil; S I Staprans; D C Montefiori; Y Xu; J G Herndon; L S Wyatt; M A Candido; N L Kozyr; P L Earl; J M Smith; H L Ma; B D Grimm; M L Hulsey; J Miller; H M McClure; J M McNicholl; B Moss; H L Robinson
Journal:  Science       Date:  2001-04-06       Impact factor: 47.728

4.  Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

Authors:  John W Shiver; Tong-Ming Fu; Ling Chen; Danilo R Casimiro; Mary-Ellen Davies; Robert K Evans; Zhi-Qiang Zhang; Adam J Simon; Wendy L Trigona; Sheri A Dubey; Lingyi Huang; Virginia A Harris; Romnie S Long; Xiaoping Liang; Larry Handt; William A Schleif; Lan Zhu; Daniel C Freed; Natasha V Persaud; Liming Guan; Kara S Punt; Aimin Tang; Minchun Chen; Keith A Wilson; Kelly B Collins; Gwendolyn J Heidecker; V Rose Fernandez; Helen C Perry; Joseph G Joyce; Karen M Grimm; James C Cook; Paul M Keller; Denise S Kresock; Henryk Mach; Robert D Troutman; Lynne A Isopi; Donna M Williams; Zheng Xu; Kathryn E Bohannon; David B Volkin; David C Montefiori; Ayako Miura; Georgia R Krivulka; Michelle A Lifton; Marcelo J Kuroda; Jörn E Schmitz; Norman L Letvin; Michael J Caulfield; Andrew J Bett; Rima Youil; David C Kaslow; Emilio A Emini
Journal:  Nature       Date:  2002-01-17       Impact factor: 49.962

5.  Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.

Authors:  Dan H Barouch; Jennifer Kunstman; Marcelo J Kuroda; Jörn E Schmitz; Sampa Santra; Fred W Peyerl; Georgia R Krivulka; Kristin Beaudry; Michelle A Lifton; Darci A Gorgone; David C Montefiori; Mark G Lewis; Steven M Wolinsky; Norman L Letvin
Journal:  Nature       Date:  2002-01-17       Impact factor: 49.962

Review 6.  Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection.

Authors:  D O'Connor; T Friedrich; A Hughes; T M Allen; D Watkins
Journal:  Immunol Rev       Date:  2001-10       Impact factor: 12.988

7.  Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.

Authors:  E John Wherry; Joseph N Blattman; Kaja Murali-Krishna; Robbert van der Most; Rafi Ahmed
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

8.  Persistent numbers of tetramer+ CD8(+) T cells, but loss of interferon-gamma+ HIV-specific T cells during progression to AIDS.

Authors:  Stefan Kostense; Kristin Vandenberghe; Jeanine Joling; Debbie Van Baarle; Nening Nanlohy; Erik Manting; Frank Miedema
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

9.  Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys.

Authors:  Dan H Barouch; Jennifer Kunstman; Jennifer Glowczwskie; Kevin J Kunstman; Michael A Egan; Fred W Peyerl; Sampa Santra; Marcelo J Kuroda; Jörn E Schmitz; Kristin Beaudry; Georgia R Krivulka; Michelle A Lifton; Darci A Gorgone; Steven M Wolinsky; Norman L Letvin
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.

Authors:  A D Kelleher; C Long; E C Holmes; R L Allen; J Wilson; C Conlon; C Workman; S Shaunak; K Olson; P Goulder; C Brander; G Ogg; J S Sullivan; W Dyer; I Jones; A J McMichael; S Rowland-Jones; R E Phillips
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

View more
  8 in total

1.  Dynamic interaction between astrocytes and infiltrating PBMCs in context of neuroAIDS.

Authors:  Maureen H Richards; Srinivas D Narasipura; Stephanie Kim; Melanie S Seaton; Victoria Lutgen; Lena Al-Harthi
Journal:  Glia       Date:  2014-10-21       Impact factor: 7.452

2.  Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infection.

Authors:  Joseph N Blattman; E John Wherry; Sang-Jun Ha; Robbert G van der Most; Rafi Ahmed
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

3.  The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infection.

Authors:  Leslie L Chavez; Miles P Davenport; John W Shiver; Lynda G Tussey; Kara S Cox; Margaret Bachinsky; Fubao Wang; Lingyi Huang; William A Schleif; Mary-Ellen Davies; Aimin Tang; Danilo R Casimiro; Alan S Perelson; Ruy M Ribeiro
Journal:  Virology       Date:  2008-09-14       Impact factor: 3.616

4.  Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge.

Authors:  John Schell; Nina F Rose; Nicole Fazo; Preston A Marx; Meredith Hunter; Elizabeth Ramsburg; David Montefiori; Patricia Earl; Bernard Moss; John K Rose
Journal:  Vaccine       Date:  2009-01-07       Impact factor: 3.641

5.  Migration of CD8+ T Cells into the Central Nervous System Gives Rise to Highly Potent Anti-HIV CD4dimCD8bright T Cells in a Wnt Signaling-Dependent Manner.

Authors:  Maureen H Richards; Srinivas D Narasipura; Melanie S Seaton; Victoria Lutgen; Lena Al-Harthi
Journal:  J Immunol       Date:  2015-11-18       Impact factor: 5.422

6.  Transduction of SIV-specific TCR genes into rhesus macaque CD8+ T cells conveys the ability to suppress SIV replication.

Authors:  Eugene V Barsov; Matthew T Trivett; Jacob T Minang; Haosi Sun; Claes Ohlen; David E Ott
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

7.  Relevance of long-lived CD8(+) T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination.

Authors:  José R Vasconcelos; Mariana R Dominguez; Adriano F Araújo; Jonatan Ersching; Cibele A Tararam; Oscar Bruna-Romero; Mauricio M Rodrigues
Journal:  Front Immunol       Date:  2012-12-04       Impact factor: 7.561

Review 8.  DNA/MVA Vaccines for HIV/AIDS.

Authors:  Smita S Iyer; Rama R Amara
Journal:  Vaccines (Basel)       Date:  2014-02-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.